Bioavailability Assessment via Bacterial Viability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the bioavailability of metal ions in compositions, such as those used in oral care, rely solely on solubility measurements, which may not accurately reflect their ability to exert antimicrobial effects due to potential retention of soluble ions in insoluble fractions, leading to inaccurate assessments of their effectiveness.
Innovation Solution
A method involving the incubation of bacterial cells with metal ion-containing compositions, followed by the use of metabolic indicator dyes to determine viability, allowing for a quantitative assessment of bioavailability based on antimicrobial activity, rather than solubility alone, using zinc ions as a source and optionally incorporating chelating agents like EDTA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Difficulty of detecting and measuring
If solubility measurements are used to determine bioavailability, then the measurement process is simple, but the accuracy of bioavailability assessment deteriorates
Solution Approach 1:
The patent introduces bacterial cells as an intermediary system to indirectly measure metal ion bioavailability. Instead of directly measuring metal ion concentration, the method uses bacterial viability as a mediator that reflects the actual bioavailable metal ion content, thereby resolving the inaccuracy of direct solubility measurements
Solution Approach 2:
The patent replaces the mechanical/chemical measurement system (centrifugation and solubility measurement) with a biological measurement system (bacterial viability assessment using metabolic indicator dyes). This substitution allows for more accurate bioavailability assessment by using biological response as the measurement basis
2Ease of manufacture
If centrifugation is used to separate soluble and insoluble fractions, then the separation process is straightforward, but soluble metal ions are retained in the insoluble fraction leading to measurement error
Solution Approach 1:
The patent extracts the core functional property (bioavailability) from the problematic measurement approach (solubility). By focusing on the biological effect rather than the physical state, the method eliminates the need for centrifugation and the associated retention errors while maintaining measurement reliability
3Loss of time
If solubility-based methods are used to assess bioavailability, then the assessment method is quick, but it provides inaccurate indication of actual metal ion availability
Solution Approach 1:
The patent changes the measurement parameter from physical solubility to biological viability. This parameter transformation allows the method to directly assess the functional availability of metal ions while maintaining reasonable assessment time through high-throughput microbiological techniques
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more accurate measurement of bioavailability by assessing the antimicrobial effect on bacterial cells, indicating that high viability correlates with low bioavailability and low viability with high bioavailability, thus overcoming the limitations of solubility-based methods.
Implementation Method 1
the use of metabolic indicator dyes to determine viability
Data Source
AI summary
Provided herein is a method for determining the bioavailability of a metal ion in a composition comprising a source of the metal ion, wherein the metal ion has antimicrobial activity, and wherein the method comprises: a) incubating a sample of the composition with bacterial cells, and b) determining the viability of the bacterial cells after incubation. The method is useful for determining the effect of agents on the bioavailability of metal ions in a composition.